Future of the Global Prenatal Testing & Newborn Screening Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Prenatal Testing & Newborn Screening Market Size Growth Forecast: What to Expect by 2025?
The expanse of the prenatal screening and newborn testing sector has demonstrated brisk expansion recently, projecting an escalation from its 2024 valuation of $6.24 billion up to $6.98 billion by 2025, reflecting an 11.8% compound annual growth rate. This momentum seen during the prior period is fundamentally linked to progress in genetic analysis techniques, a rising average age for expectant mothers, heightened levels of knowledge and instruction regarding these procedures, alongside supportive healthcare directives and formalized rules.

How Will the Prenatal Testing & Newborn Screening Market Size Evolve and Grow by 2029?
The domain concerned with prenatal testing and screening performed on newborns anticipates a swift expansion over the forthcoming years, projecting to reach a substantial valuation of ten point nine nine billion dollars by the year 2029, fueled by an estimated compound annual growth rate of twelve point zero percent. This forward surge during the anticipated timeframe is primarily driven by the increased utilization of genetic counseling services, ongoing leaps in technical capabilities, the rise of point-of-care diagnostic solutions, and the growing adoption of both telehealth platforms and remote patient oversight. Key developments shaping this market outlook encompass non-invasive prenatal testing procedures (nipt), preimplantation genetic screening (pgt), remote medical consultations via telemedicine, enhanced maternal blood sample analysis, and specialized screening programs targeting conditions like hemoglobinopathies and sickle cell disease.

View the full report here:
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

What Drivers Are Propelling the Growth of Prenatal Testing & Newborn Screening Market Forward?
The increasing frequency of inherited disorders observed in newborns has been a key factor driving the expansion of the prenatal testing and newborn screening sector. Genetic conditions, encompassing illnesses such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease, are cataloged by the World Health Organization. Notably, Sickle Cell Anemia frequently impacts millions globally, being especially widespread among populations descending from regions including Africa, America, Cuba, Central America, Saudi Arabia, and India. To illustrate the severity, data released in February 2023 by the Rady Children's Institute for Genomic Medicine, a US research entity, indicated that a significant 41% of infant fatalities observed during a study at Rady Children's Hospital were linked to single-locus (Mendelian) genetic ailments, thereby intensifying the need for and fueling the growth trend within the prenatal screening and newborn diagnostic market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Which Emerging Trends Are Transforming the Prenatal Testing & Newborn Screening Market in 2025?
Leading firms within the prenatal testing and newborn screening sector are concentrating their efforts on rolling out innovative initiatives that leverage rapid Whole Genome Sequencing (rWGS) technology to swiftly and precisely pinpoint congenital health issues in infants, thereby facilitating prompt identification and therapeutic measures to enhance overall patient wellness. This sophisticated genomic methodology, known as rWGS, involves the swift sequencing of a person's complete DNA blueprint; instead of scrutinizing only select genes or segments like conventional diagnostic approaches, rWGS encompasses the entirety of an individual's genome to uncover DNA variations linked to illnesses or conditions. Demonstrating this, the Rady Children's Institute for Genomic Medicine, situated in the United States, initiated BeginNGS in June 2022, a groundbreaking program engineered to identify and diagnose around 400 genetic ailments for which therapies currently exist, all prior to the onset of clinical signs, furthermore, BeginNGS is refining its genomic sequencing workflows with aspirations to broaden its testing repertoire to encompass roughly 1,000 different disorders, ultimately aiming to facilitate screening for 3.7 million newborns each year across the United States, positioning this as a routine hospital procedure.

What Are the Key Segments in the Prenatal Testing & Newborn Screening Market?
The prenatal testing & newborn screeningmarket covered in this report is segmented -

1) By Diagnostic Type: Non-Invasive; Invasive
2) By Technology: Screening Technology; Diagnostic Technology
3) By End user: Hospitals; Diagnostic centers

Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

Who Are the Key Players Shaping the Prenatal Testing & Newborn Screening Market's Competitive Landscape?
Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

What Geographic Markets Are Powering Growth in the Prenatal Testing & Newborn Screening Market?
North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.